UBP Investment Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$440K Sell
12,040
-5,650
-32% -$252K 0.23% 61
2022
Q2
$750K Sell
17,690
-44,610
-72% -$2.12M 0.3% 55
2022
Q1
$240K Buy
62,300
+42,010
+207% +$2.45M 0.09% 95
2021
Q4
$1.46M Buy
20,290
+150
+0.7% +$9.4K 0.53% 35
2021
Q3
$1.15M Sell
20,140
-5,310
-21% -$323K 0.45% 49
2021
Q2
$1.66M Buy
25,450
+8,330
+49% +$526K 0.61% 33
2021
Q1
$1.02M Buy
17,120
+11,300
+194% +$616K 0.42% 49
2020
Q4
$275K Buy
+5,820
New +$245K 0.14% 63
2020
Q3
Sell
-6,290
Closed -$203K 65
2020
Q2
$203K Buy
+6,290
New +$172K 0.16% 55

Other funds holding LRCX

UBP Investment Advisors's LRCX Position: Q3 2022 in Review

UBP Investment Advisors reduced its Lam Research (LRCX) stake by 32% in Q3 2022, selling an estimated $252K and leaving 12,040 shares worth $440K. The position accounts for 0.23% of the portfolio, ranked #61.

UBP Investment Advisors first reported a position in LRCX in Q2 2020 and has held it in 9 quarters since. The position peaked at $1.66M in Q2 2021. 1,271 funds tracked by Wall St. Rank hold LRCX as of Q3 2022.

  • UBP Investment Advisors held 12,040 shares of Lam Research worth $440K as of Q3 2022.
  • UBP Investment Advisors sold 5,650 Lam Research shares in Q3 2022, an estimated $252K.
  • Lam Research made up 0.23% of UBP Investment Advisors's portfolio in Q3 2022, its #61 holding.
  • UBP Investment Advisors first reported a position in Lam Research in Q2 2020 and has held it in 9 quarters since.
  • UBP Investment Advisors's Lam Research position peaked at $1.66M in Q2 2021.
  • 1,271 funds tracked by Wall St. Rank held Lam Research as of Q3 2022.

Based on UBP Investment Advisors's 13F filing for Q3 2022, filed 4 Oct 2022.